Fifth and final article in a series on managing bone allografts. A unified program for managing biologics, including tissues and blood, has helped a Massachusetts hospital to meet regulatory requirements, track adverse events, and have a consistent process for bringing new tissues into the organization. The 2½-year-old Biovigilance Program at…

Read More

Second in a series on managing bone allografts. Bone-graft substitutes in all of their many forms have one purpose—to replicate the "gold standard" for bone repair and healing—the patient's own bone. Though a patient's own tissue—an autograft—is the ideal replacement for injured or diseased bone, an autograft may not be…

Read More

Asimultaneous quintuple kidney transplant took place at Baltimore's Johns Hopkins Hospital on Nov 14, 2006. The historic event was made possible by a kidney swap involving 4 transplant candidates who each had a relative willing to donate a kidney and a fifth candidate who matched a donor who had offered…

Read More